Bérengère Genin

Bérengère Genin is the current head of academics and research business unit at OncoDNA. Bérengère has also previously worked as a project leader at IntegraGen, as well as a bioinformatician at Sanofi-Aventis.

Bérengère has always been interested in the field of genetics and its potential implications for personalized medicine. This led their to pursue a career in bioinformatics, where they could use their skills in computer programming and mathematics to analyze and interpret large data sets.

At OncoDNA, Bérengère is responsible for managing the company's academic and research partnerships, as well as overseeing the development of new genomic testing products. Bérengère is also involved in the company's efforts to commercialize its technology, including the launch of OncoDNA's first direct-to-consumer product.

Bérengère is a strong advocate for the use of genomic testing in cancer treatment and prevention. Bérengère believes that by understanding an individual's unique genetic makeup, we can tailor treatments to their specific needs and improve outcomes.

Bérengère Genin has a executive certificate in Chief Digital Officer & Digital Champion - Business Transformers from CentraleSupélec. Bérengère also has a DESS in genetics & informatics from Université d'Évry as well as an IUP in genetics & informatics from the same school. Finally, they have a Master 2 (M2) in Génie Biologique et Informatique from Université d'Évry.

Bérengère Genin works with Emmanuel Martin - COO, Jean-Pol Detiffe - Chief Strategy & Innovation Officer, and Pierre Flamant - CFO. Bérengère Genin reports to Bernard Courtieu, CEO.